Mark T DuPriest

Title: Mark T DuPriest: Innovator in Pharmaceutical Chemistry

Introduction

Mark T DuPriest is a notable inventor based in Arlington, TX (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antihypertensive and radioprotective effects. With a total of 2 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

DuPriest's latest patents include innovative compounds such as high energy ionizing protective 2,3-diamino-1,4-butanedithiol. This patent discloses 2,3-diamino-1,4-butanedithiol, 4,5-diamino-1,2-dithiane, and their N-acyl and N-alkyl derivatives. The patent also outlines processes for preparing these compounds, pharmaceutical compositions that include them, and methods of treatment that involve administering these compounds when an antihypertensive or radioprotective effect is indicated. Another significant patent focuses on a method for treating hypertension with 2,3-diamino-1,4-butanedithiol, further emphasizing the therapeutic potential of these compounds.

Career Highlights

Mark T DuPriest is currently associated with Alcon Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

DuPriest collaborates with various professionals in his field, including his coworker Billie M York. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Mark T DuPriest stands out as an influential inventor in pharmaceutical chemistry, with a focus on innovative treatments for hypertension and radioprotection. His contributions through patents and collaborations highlight the importance of research in improving healthcare solutions.